产品说明
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
生化/生理作用
文拉法辛是抗抑郁药。文拉法辛在人中的抗抑郁作用机制与其在中枢神经系统中神经递质活性的增强有关。文拉法辛是神经元 5-羟色胺和去甲肾上腺素再摄取的有效抑制剂,是多巴胺再摄取的弱抑制剂。在体外,文拉法辛对毒蕈碱、组胺能或 α-1 肾上腺素能受体无明显活性。文拉法辛不具有 MAO 抑制剂活性。
包装
Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
注意
Please find SDS provided by EDQM here..
其他说明
Sales restrictions may apply.
基本信息
经验(实验)分子式 | C17H27NO2 · HCl |
分子量 | 313.86 |
MDL编号 | MFCD03658865 |
PubChem化学物质编号 | 329831036 |
NACRES | NA.24 |
产品性质
等级 | pharmaceutical primary standard |
manufacturer/tradename | EDQM |
application(s) | pharmaceutical (small molecule) |
格式 | neat |
SMILES string | Cl[H].COc1ccc(cc1)C(CN(C)C)C2(O)CCCCC2 |
InChI | 1S/C17H27NO2.ClH/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14;/h7-10,16,19H,4-6,11-13H2,1-3H3;1H |
InChI key | QYRYFNHXARDNFZ-UHFFFAOYSA-N |
Gene Information | human ... SLC6A2(6530), SLC6A4(6532) |
安全信息
象形图 | |
危险声明 | H411 |
预防措施声明 | P273 - P391 - P501 |
危险分类 | Aquatic Chronic 2 |
储存分类代码 | 11 - Combustible Solids |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |
Sigma-Aldrich